Trending

Panacea Pharmaceuticals enrolls patient for PAN-301-1 Phase 1 Clinical Trial

Read more

TVA Medical’s everlinQ endoAVF System exhibits positive Clinical results

Read more

Seattle Genetics merges with Cascadian Therapeutics

Read more

Hisamitsu and Noven Pharma declares transdermal patch for Schizophrenia

Read more

Vertex Pharmaceuticals selects VX-659 and VX-445 in Phase 3 for Cystic Fibrosis

Read more

FDA approval sought for Ferring Pharmaceutical’s ZOMACTON

Read more

QIAGEN N.V. obtains STAT-Dx

Read more

Authentidate Holding announced Corporate name change to Aeon Global Health Corp

Read more

Medidata partners Syapse to transform Oncology Clinical Trials

Read more

R. Michael Gendreau appointed Chief Medical Officer by Intec Pharma

Read more